View : 18 Download: 4

Phase II randomized trial of neoadjuvant metformin plus letrozole versus placebo plus letrozole for estrogen receptor positive postmenopausal breast cancer (METEOR)

Title
Phase II randomized trial of neoadjuvant metformin plus letrozole versus placebo plus letrozole for estrogen receptor positive postmenopausal breast cancer (METEOR)
Authors
Kim J.Lim W.Kim E.-K.Kim M.-K.Paik N.-S.Jeong S.-S.Yoon J.-H.Park C.H.Ahn S.H.Kim L.S.Han S.Nam S.J.Kang H.-S.Kim S.I.Yoo Y.B.Jeong J.Kim T.H.Kang T.Kim S.-W.Jung Y.Lee J.E.Kim K.S.Yu J.-H.Chae B.J.Jung S.-Y.Kang E.Choi S.Y.Moon H.-G.Noh D.-Y.Han W.
Ewha Authors
임우성
SCOPUS Author ID
임우성scopus
Issue Date
2014
Journal Title
BMC Cancer
ISSN
1471-2407JCR Link
Citation
vol. 14, no. 1
Publisher
BioMed Central Ltd.
Indexed
SCIE; SCOPUS WOS scopus
Abstract
Estrogen receptor-positive Breast cancer; Letrozole; Metformin; Neoadjuvant
DOI
10.1186/1471-2407-14-170
Appears in Collections:
의과대학 > 의학과 > Journal papers
Files in This Item:
001.pdf(278.8 kB)Download
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE